Literature DB >> 20616011

miRNA malfunction causes spinal motor neuron disease.

Sharon Haramati1, Elik Chapnik, Yehezkel Sztainberg, Raya Eilam, Raaya Zwang, Noga Gershoni, Edwina McGlinn, Patrick W Heiser, Anne-Marie Wills, Itzhak Wirguin, Lee L Rubin, Hidemi Misawa, Clifford J Tabin, Robert Brown, Alon Chen, Eran Hornstein.   

Abstract

Defective RNA metabolism is an emerging mechanism involved in ALS pathogenesis and possibly in other neurodegenerative disorders. Here, we show that microRNA (miRNA) activity is essential for long-term survival of postmitotic spinal motor neurons (SMNs) in vivo. Thus, mice that do not process miRNA in SMNs exhibit hallmarks of spinal muscular atrophy (SMA), including sclerosis of the spinal cord ventral horns, aberrant end plate architecture, and myofiber atrophy with signs of denervation. Furthermore, a neurofilament heavy subunit previously implicated in motor neuron degeneration is specifically up-regulated in miRNA-deficient SMNs. We demonstrate that the heavy neurofilament subunit is a target of miR-9, a miRNA that is specifically down-regulated in a genetic model of SMA. These data provide evidence for miRNA function in SMN diseases and emphasize the potential role of miR-9-based regulatory mechanisms in adult neurons and neurodegenerative states.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20616011      PMCID: PMC2919953          DOI: 10.1073/pnas.1006151107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  75 in total

1.  TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor.

Authors:  I-Fan Wang; Lien-Szn Wu; Hsiang-Yu Chang; C-K James Shen
Journal:  J Neurochem       Date:  2007-12-15       Impact factor: 5.372

Review 2.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

3.  Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus.

Authors:  Tigwa H Davis; Trinna L Cuellar; Selina M Koch; Allison J Barker; Brian D Harfe; Michael T McManus; Erik M Ullian
Journal:  J Neurosci       Date:  2008-04-23       Impact factor: 6.167

4.  Multilevel regulation of gene expression by microRNAs.

Authors:  Eugene V Makeyev; Tom Maniatis
Journal:  Science       Date:  2008-03-28       Impact factor: 47.728

5.  Mechanism of type 1 muscle fibre grouping.

Authors:  C J Morris; A L Woolf
Journal:  Nature       Date:  1970-06-13       Impact factor: 49.962

6.  Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration.

Authors:  Trinna L Cuellar; Tigwa H Davis; Peter T Nelson; Gabriel B Loeb; Brian D Harfe; Erik Ullian; Michael T McManus
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-02       Impact factor: 11.205

7.  DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4).

Authors:  Ying-Zhang Chen; Craig L Bennett; Huy M Huynh; Ian P Blair; Imke Puls; Joy Irobi; Ines Dierick; Annette Abel; Marina L Kennerson; Bruce A Rabin; Garth A Nicholson; Michaela Auer-Grumbach; Klaus Wagner; Peter De Jonghe; John W Griffin; Kenneth H Fischbeck; Vincent Timmerman; David R Cornblath; Phillip F Chance
Journal:  Am J Hum Genet       Date:  2004-04-21       Impact factor: 11.025

8.  TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis.

Authors:  Edor Kabashi; Paul N Valdmanis; Patrick Dion; Dan Spiegelman; Brendan J McConkey; Christine Vande Velde; Jean-Pierre Bouchard; Lucette Lacomblez; Ksenia Pochigaeva; Francois Salachas; Pierre-Francois Pradat; William Camu; Vincent Meininger; Nicolas Dupre; Guy A Rouleau
Journal:  Nat Genet       Date:  2008-03-30       Impact factor: 38.330

9.  Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis.

Authors:  Koji Yamanaka; Seung Joo Chun; Severine Boillee; Noriko Fujimori-Tonou; Hirofumi Yamashita; David H Gutmann; Ryosuke Takahashi; Hidemi Misawa; Don W Cleveland
Journal:  Nat Neurosci       Date:  2008-02-03       Impact factor: 24.884

10.  TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.

Authors:  Jemeen Sreedharan; Ian P Blair; Vineeta B Tripathi; Xun Hu; Caroline Vance; Boris Rogelj; Steven Ackerley; Jennifer C Durnall; Kelly L Williams; Emanuele Buratti; Francisco Baralle; Jacqueline de Belleroche; J Douglas Mitchell; P Nigel Leigh; Ammar Al-Chalabi; Christopher C Miller; Garth Nicholson; Christopher E Shaw
Journal:  Science       Date:  2008-02-28       Impact factor: 47.728

View more
  148 in total

Review 1.  Local RNA translation at the synapse and in disease.

Authors:  Liqun Liu-Yesucevitz; Gary J Bassell; Aaron D Gitler; Anne C Hart; Eric Klann; Joel D Richter; Stephen T Warren; Benjamin Wolozin
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 2.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

3.  MicroRNAs control neurobehavioral development and function in zebrafish.

Authors:  Tamara L Tal; Jill A Franzosa; Susan C Tilton; Kenneth A Philbrick; Urszula T Iwaniec; Russell T Turner; Katrina M Waters; Robert L Tanguay
Journal:  FASEB J       Date:  2012-01-17       Impact factor: 5.191

4.  Temporal microRNA expression during in vitro myogenic progenitor cell proliferation and differentiation: regulation of proliferation by miR-682.

Authors:  Yongxin Chen; Jonathan Gelfond; Linda M McManus; Paula K Shireman
Journal:  Physiol Genomics       Date:  2010-09-14       Impact factor: 3.107

5.  The preclinical discovery of amyotrophic lateral sclerosis drugs.

Authors:  Marcie A Glicksman
Journal:  Expert Opin Drug Discov       Date:  2011-10-25       Impact factor: 6.098

6.  Formaldehyde, Epigenetics, and Alzheimer's Disease.

Authors:  Fei Wang; Danqi Chen; Peipei Wu; Catherine Klein; Chunyuan Jin
Journal:  Chem Res Toxicol       Date:  2019-04-19       Impact factor: 3.739

Review 7.  Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.

Authors:  Rachna S Pandya; Lilly L J Mao; Edward W Zhou; Robert Bowser; Zhenglun Zhu; Yongjin Zhu; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-03

8.  Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure.

Authors:  Neal D Amin; Ge Bai; Jason R Klug; Dario Bonanomi; Matthew T Pankratz; Wesley D Gifford; Christopher A Hinckley; Matthew J Sternfeld; Shawn P Driscoll; Bertha Dominguez; Kuo-Fen Lee; Xin Jin; Samuel L Pfaff
Journal:  Science       Date:  2015-12-18       Impact factor: 47.728

Review 9.  MicroRNAs in neurodegenerative diseases and their therapeutic potential.

Authors:  Eunsung Junn; M Maral Mouradian
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

Review 10.  Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.

Authors:  Paul Hagerman
Journal:  Acta Neuropathol       Date:  2013-06-21       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.